Seminars in Spine Surgery
Volume 18, Issue 1 , Pages 15-21 , March 2006

Applications of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Spinal Surgery

  • Gerard K. Jeong, MD

      Affiliations

    • Tucson Orthopaedic Institute Spine Center, Tucson, AZ
    • Corresponding Author InformationAddress reprint requests to Gerard K. Jeong, MD, Tucson Orthopaedic Institute, PC, The Spine Center, 2424 North Wyatt Drive, Suite 100, Tucson, AZ 85750
    • ,
  • Harvinder S. Sandhu, MD

      Affiliations

    • Hospital for Special Surgery, New York, NY

References 

  1. Urist MR . Bone (formation by autoinduction) . Science . 1965;150(698):893–899
  2. Sampath TK , Coughlin JE , Whetstone RM , et al.   Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily . J Biol Chem . 1990;265(22):13198–13205
  3. Sampath TK , Reddi AH . Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation . Proc Natl Acad Sci USA . 1981;78(12):7599–7603
  4. Boden SD . Bioactive factors for bone tissue engineering . Clin Orthop Relat Res . 1999;367(suppl):S84–S94
  5. Luyten FP , Cunningham NS , Ma S , et al.   Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation . J Biol Chem . 1989;264(23):13377–13380
  6. Ozkaynak E , Rueger DC , Drier EA , et al.   OP-1 cDNA encodes an osteogenic protein in the TGF-beta family . EMBO J . 1990;9(7):2085–2093
  7. Katagiri T , Yamaguchi A , Ikeda T , et al.   The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2 . Biochem Biophys Res Commun . 1990;172(1):295–299
  8. Takuwa Y , Ohse C , Wang EA , et al.   Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1 . Biochem Biophys Res Commun . 1991;174(1):96–101
  9. Yeh LC , Adamo ML , Duan C , et al.   Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms . J Cell Physiol . 1998;175(1):78–88
  10. Yeh LC , Lee JC . Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells . Mol Cell Endocrinol . 1999;153(1-2):113–124
  11. Yeh LC , Unda R , Lee JC . Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts . J Cell Physiol . 2000;185(1):87–97
  12. Administration FaD. Document P000058-InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Device. July 2, 2002. http://wwwfdagov/cdrh/PDF/p000054apdf.
  13. Sandhu H , Kabo JM , Turner AS . rhBMP-2 augmentation of titanium fusion cages for experimental anterior lumbar fusion . Vancouver, BC: North Am Spine Society; 1996;
  14. Sandhu HS , Toth JM , Diwan AD , et al.   Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion . Spine . 2002;27(6):567–575
  15. Zdeblick TA, Heim SE, Kleeman TJ: Laparoscopic approach with tapered metal cages: rhBMP-2 vs. autograft. Read at the Annual Meeting of the North American Spine Society; 2001 Oct 31-Nov 3; Seattle, WA
  16. Boden SD , Martin GJ , Horton WC , et al.   Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage . J Spinal Disord . 1998;11(2):95–101
  17. Hecht BP , Fischgrund JS , Herkowitz HN , et al.   The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model . Spine . 1999;24(7):629–636
  18. Sandhu HS , Kanim LE , Kabo JM , et al.   Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model . Spine . 1995;20(24):2669–2682
  19. Sandhu HS , Kanim LE , Kabo JM , et al.   Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion . Spine . 1996;21(18):2115–2122
  20. Sandhu HS , Kanim LE , Toth JM , et al.   Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements . Spine . 1997;22(11):1171–1180
  21. Fischgrund JS , James SB , Chabot MC , et al.   Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model . J Spinal Disord . 1997;10(6):467–472
  22. Schimandle JH , Boden SD , Hutton WC . Experimental spinal fusion with recombinant human bone morphogenetic protein-2 . Spine . 1995;20(12):1326–1337
  23. Martin GJ , Boden SD , Marone MA , et al.   Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate (important lessons learned regarding dose, carrier, and safety) . J Spinal Disord . 1999;12(3):179–186
  24. Boden SD , Martin GJ , Morone MA , et al.   Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate . Spine . 1999;24(12):1179–1185
  25. Suh DY , Boden SD , Louis-Ugbo J , et al.   Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate . Spine . 2002;27(4):353–360
  26. Suh DY, Boden SD, Ugbo JL: Use of rhBMP-2 supplemented with allograft bone chips in posterolateral fusions in nonhuman primates. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2002 Feb 13-17; Dallas, TX
  27. Minamide A, Akamaru A, Ugbo J, et al: Use of rhBMP-2 supplemented with allograft bone chips in posterolateral fusions in nonhuman primates. Read at the Annual Meeting of the North American Spine Society; 2001 Oct 31-Nov 3; Seattle, WA
  28. Martin GJ , Boden SD , Titus L . Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion . Spine . 1999;24(21:2188–2193 discussion 93-94
  29. Silcox DH , Boden SD , Schimandle JH , et al.   Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract . Spine . 1998;23:291–296
  30. Boden SD , Zdeblick TA , Sandhu HS , et al.   The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report . Spine . 2000;25(3):376–381
  31. Gornet MF, Burkus K, Dickman CA: rhBMP-2 with tapered cages: a prospective, randomized lumbar fusion study. Read at the Annual Meeting of the North American Spine Society; 2001 Oct 31-Nov 3; Seattle, WA
  32. Burkus JK , Gornet MF , Dickman CA , et al.   Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages . J Spinal Disord Tech . 2002;15(5):337–349
  33. Burkus JK , Transfeldt EE , Kitchel SH , et al.   Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2 . Spine . 2002;27(21):2396–2408
  34. Poynton AR , Lane JM . Safety profile for the clinical use of bone morphogenetic proteins in the spine . Spine . 2002;27(16 suppl 1):S40–S48
  35. Boden SD , Kang J , Sandhu H , et al.   Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies . Spine . 2002;27(23):2662–2673
  36. Vaccaro AR , Patel T , Fischgrund J , et al.   A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions . Eur Spine J . 2003;12(5):495–500
  37. Vaccaro AR , Patel T , Fischgrund J , et al.   A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions . Eur Spine J . 2005;14:623–629
  38. Vaccaro AR , Patel T , Fischgrund J , et al.   A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis . Spine . 2004;29(17):1885–1892
  39. Sandhu HS, Kanim LE, Dawson ED. The safety and efficacy of purified native human bone morphogenic protein for spinal fusion. A ten-year follow-up study. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 1997 Feb 13-17; San Francisco, CA
  40. Polly DW , Ackerman SJ , Shaffrey CI , et al.   A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion . Orthopedics . 2003;26(10):1027–1037
  41. Tim Yoon S , Su Kim K , Li J , et al.   The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro . Spine . 2003;28(16):1773–1780
  42. Li J , Yoon ST , Hutton WC . Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells . J Spinal Disord Tech . 2004;17(5):423–428
  43. Kim DJ , Moon SH , Kim H , et al.   Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells . Spine . 2003;28(24):2679–2684
  44. Sobajima S , Shimer AL , Chadderdon RC , et al.   Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction . Spine J . 2005;5(1):14–23
  45. Takae R , Matsunaga S , Origuchi N , et al.   Immunolocalization of bone morphogenetic protein and its receptors in degeneration of intervertebral disc . Spine . 1999;24(14):1397–1401

PII: S1040-7383(06)00005-0

doi: 10.1053/j.semss.2006.01.003

Seminars in Spine Surgery
Volume 18, Issue 1 , Pages 15-21 , March 2006

Article Tools